There is a wealth of information for the Fellowship applicant both pre- and post-application and match regarding the Graduate Medical Education (GME) program here at Yale, as well as information about Yale New Haven Hospital, Yale University and New Haven.
Yale Medical Oncology-Hematology Program
The Yale Medical Oncology-Hematology Fellowship Program is a 36-month training program that adheres to the ACGME and ABIM guidelines for combined training in Medical Oncology and Hematology. The fellowship program provides comprehensive clinical training in the diagnosis and management of neoplastic and benign hematologic disorders and a robust research experience to prepare fellows for a career in academic medicine. Fellows have the opportunity to train in multiple health care settings and to care for a diverse patient population with respect to gender and socio-economic backgrounds.
The goal of the Yale Medical Oncology-Hematology Fellowship Program is to train the next generation of academic hematologists and oncologists devoted to laboratory-based or patient-oriented investigation. Thus, the program is designed and structured to provide not only comprehensive clinical training but also a rigorous research experience to prepare fellows for careers as clinician investigators or clinician scientists in academic medicine.
Clinical Training in Year One (12 months) and Year Two (6 months):
Research Training in Year Two (6 months) and Year Three (12 months):
The second year (6 mo) and third year of training are devoted to research. All fellows are expected to engage in a hypothesis-driven research project in a clinical, translational, or basic science arena. During the research block, the fellow spends the majority of his/her time engaged in his or her research project, under the mentorship and supervision of a faculty advisor, while continuing a continuity outpatient clinic experience in disease-specific units at Yale.
2nd and 3rd year fellows are expected to present their research at least annually at the Research in Progress conference. In addition, it is expected that each fellow’s research activities will lead to at least one abstract presentation at a national meeting (e.g., ASCO, ASH, AACR) and at least one peer-reviewed publication. Concurrent course work offered through the University is recommended to augment the fellow’s research goals, and, specifically, fellows may enroll in one or more of the core courses offered through the Investigative Medicine Program (see below Research Opportunities and Programs). In addition, fellows who are pursuing a career in clinical investigation are expected to submit an application to the AACR/ASCO Workshop on Methods in Clinical Cancer Research (“Vail Workshop”) or the ASH Clinical Training Research Institute.
Research Opportunities and Programs:
The Yale Internal Medicine Residency Program offers a research track (the ABIM Physician-Scientist Research Pathway) for internal medicine residents who are fully committed to a research-based career pathway. Applicants to this program will interview with both internal medicine faculty for residency and faculty in the specialty in which they are interested. If admitted to the program, they are guaranteed a position in the Yale Hematology Oncology fellowship. Participants in this track complete two years of internal medicine residency and five years of fellowship, during which they will focus on research for 3.5 years. At Yale, during the five years of fellowship, fellows have guaranteed salary support. Applicants are expected to have a PhD or have done significant basic, translational or clinical research. Although not a formal prerequisite, publication in peer-reviewed journals is expected for applicants to this program in hematology or oncology. For more information, see
Didactic Sessions, Conferences, Tumor Boards:
The clinical and research training of the Medical Oncology-Hematology Fellowship is enhanced by several weekly lectures, conferences, seminars, and interdisciplinary tumor boards which include the following:
Asterisk (*) indicates mandatory attendance by fellows. Fellows are expected to attend 70% of mandatory conferences.
- Medical Oncology-Hematology Core Curriculum Course * is a weekly lecture series providing a comprehensive review of all aspects of medical oncology and hematology including oncologic emergencies, pharmacology, palliative care, biostatistics and clinical trial design, cancer epidemiology, cancer genetics, and in-depth reviews of each specific neoplastic and benign hematologic disease. The disease-specific reviews include the relevant basic biology, pathogenesis, epidemiology, staging, use of imaging, prognostic variables, and treatment. This course runs over 18 months.
- Cancer Center Grand Rounds * is a weekly forum for Yale faculty and guest speakers to provide state-of-the-art updates on a broad array of cancer-related topics.
- Journal Club * is a twice monthly (September - June) presentation at which important articles relevant to hematology-oncology are critically reviewed and presented by the fellows, with input and mentoring from appropriate faculty members.
- Research in Progress meeting (RIP) * is a weekly conference (September - May) where faculty and fellows present their research.
- New Patient Conference * is a weekly conference presented in a “morning report” format, new patients seen by the first year fellows are presented to the Yale Cancer Center Director, for case-based discussion. Attending faculty members are active participants, contributing their expertise to the discussion. In addition, this conference is used as a forum to review complications of treatment and adverse outcomes in the format of a Morbidity and Mortality Conference, three-four times annually.
- Disease-specific Case Conference * is a weekly conference in which new patients from one disease-specific unit are presented to an attending physician with expertise in that disease area for a detailed case-based discussion of staging, biology, treatment, with emphasis on evidence-based management and review of the use of specific therapeutic agents.
- Hematology/Hematopathology Conference * is a weekly case-based conference in which benign and malignant hematology cases are discussed with the participation of the hematopathologists. An important aspect of this conference is review of peripheral blood smears, bone marrow aspirates and biopsies. Specialists from the Department of Laboratory Medicine, including the Blood Bank, are invited to participate to discuss specific cases.
- Tumor Boards are interdisciplinary meetings to present new patients, review pathology and radiographic studies, and discuss evidence-based management; tumor boards are held weekly for each multidisciplinary disease-specific unit.
Program Leadership and Administration:
Dr. Roy Herbst and Dr. Madhav Dhodapkar are the Chiefs of the Section of Medical Oncology and the Section of Hematology, respectively. Dr. Jill Lacy is the Director of the Medical Oncology-Hematology Fellowship Training Program. Dr. Nikolai Podoltsev is the Associate Program Director for Hematology and Dr. Michael Hurwitz is the Associate Program Director for Research. Dr. Michal Rose is the local on-site director of fellowship activities at the VA CT Healthcare System of West Haven, where she is also the Chief of the Section of Hematology-Oncology and Cancer Center Director. The Fellowship Administrator and Coordinator is Lucilina Gilkes.